BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 26078354)

  • 1. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
    Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
    J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 4. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
    Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
    Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.
    Ge S; Zhang Q; Chen Y; Tian Y; Yang R; Chen X; Li F; Zhang B
    Toxicol Appl Pharmacol; 2021 Mar; 415():115450. PubMed ID: 33577917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine methyltransferase inhibitor 1 exhibits antitumor effects against cervical cancer
    Dong SH; Wang X; Tian SC; Ma NQ; Zhang XY; Liu Y; Zhang BL; Wu YJ
    Pharmazie; 2018 May; 73(5):269-273. PubMed ID: 29724292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
    Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRMT5 promotes colorectal cancer growth by interaction with MCM7.
    Li X; Wang X; Zhao J; Wang J; Wu J
    J Cell Mol Med; 2021 Apr; 25(7):3537-3547. PubMed ID: 33675123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression.
    Demetriadou C; Pavlou D; Mpekris F; Achilleos C; Stylianopoulos T; Zaravinos A; Papageorgis P; Kirmizis A
    Cell Death Dis; 2019 Mar; 10(3):236. PubMed ID: 30858358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell metabolic profiling of colorectal cancer via
    Ge S; Zhang Q; Tian Y; Hao L; Duan J; Zhang B
    Clin Chim Acta; 2020 Nov; 510():291-297. PubMed ID: 32707041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
    Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
    Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells.
    Bajbouj K; Ramakrishnan RK; Saber-Ayad M; Omar HA; Saheb Sharif-Askari N; Shafarin J; Elmoselhi AB; Ihmaid A; AlHaj Ali S; Alalool A; Abdullah R; Hamid Q
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of PRMT5 by AMI-1 enhances therapeutic efficacy of compound kushen injection in lung carcinoma in vitro and in vivo.
    Yang R; Dong S; Zhang J; Zhu S; Miao G; Zhang B
    Mol Cell Biochem; 2023 May; 478(5):1031-1044. PubMed ID: 36214894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.
    Yan F; Alinari L; Lustberg ME; Martin LK; Cordero-Nieves HM; Banasavadi-Siddegowda Y; Virk S; Barnholtz-Sloan J; Bell EH; Wojton J; Jacob NK; Chakravarti A; Nowicki MO; Wu X; Lapalombella R; Datta J; Yu B; Gordon K; Haseley A; Patton JT; Smith PL; Ryu J; Zhang X; Mo X; Marcucci G; Nuovo G; Kwon CH; Byrd JC; Chiocca EA; Li C; Sif S; Jacob S; Lawler S; Kaur B; Baiocchi RA
    Cancer Res; 2014 Mar; 74(6):1752-65. PubMed ID: 24453002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers.
    Prabhu L; Wei H; Chen L; Demir Ö; Sandusky G; Sun E; Wang J; Mo J; Zeng L; Fishel M; Safa A; Amaro R; Korc M; Zhang ZY; Lu T
    Oncotarget; 2017 Jun; 8(25):39963-39977. PubMed ID: 28591716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies.
    Abumustafa W; Zamer BA; Khalil BA; Hamad M; Maghazachi AA; Muhammad JS
    Biomed Pharmacother; 2022 Jan; 145():112368. PubMed ID: 34794114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
    Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
    Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
    Tarighat SS; Santhanam R; Frankhouser D; Radomska HS; Lai H; Anghelina M; Wang H; Huang X; Alinari L; Walker A; Caligiuri MA; Croce CM; Li L; Garzon R; Li C; Baiocchi RA; Marcucci G
    Leukemia; 2016 Apr; 30(4):789-99. PubMed ID: 26536822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades.
    Yan Y; Zhao P; Wang Z; Liu Z; Wang Z; Zhang J; Ding Y; Hua X; Yu L
    Aging (Albany NY); 2021 Jan; 13(3):4468-4481. PubMed ID: 33495409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.